Table 2.
Total number of visits (in-person and virtual) in 2019–2020 and the total visit volume and proportion of virtual visits in the prepandemic and pandemic periods for the INTRePID countries
| Country | Total visit volume in 2019–2020 | Total visit volume | Proportion of virtual visits (%) | ||
| Prepandemic period |
Pandemic period |
Prepandemic period |
Pandemic period |
||
| Australia | 3 295 140 | 1 330 608 | 1 306 095 | – | 41.8 |
| Canada | 1 775 258 | 714 509 | 682 448 | 0.0 | 77.0 |
| China | 131 326 | 69 495 | 49 823 | – | 0.0 |
| Norway | 29 272 958 | 11 343 591 | 11 499 561 | 3.3 | 27.0 |
| Singapore | 2 371 659 | 1 053 615 | 773 418 | – | – |
| South Korea | 117 395 | 48 495 | 41 614 | – | 2.5 |
| Sweden | 3 185 700 | 1 278 258 | 1 166 475 | 29.0 | 42.2 |
| UK* | 40 343 066 | 917* | 793* | 20.7 | 56.6 |
| USA | 396 884 | 160 683 | 142 625 | – | 27.5 |
Prepandemic period=weeks 12–52 in 2019, except in China where it was weeks 5–52 in 2019.
Pandemic period=weeks 12–52 in 2020, except in China where it was weeks 5–52 in 2020.
*Unlike the other INTRePID countries, the number of clinics that contributed data for UK varied over time. To account for this, the visit volume is reported as total visits per 10 000 patients covered in each period. For all other countries, the population is assumed to be fixed over the duration of this study.
INTRePID, INTernational ConsoRtium of Primary Care BIg Data Researchers.